key: cord-0029266-wu4m8dvp authors: Meng, Ling-bing; Xu, Hong-xuan; Shan, Meng-jie; Hu, Gai-feng; Liu, Long-teng; Chen, Yu-hui; Liu, Yun-qing; Wang, Li; Chen, Zuoguan; Li, Yong-jun; Gong, Tao; Liu, De-ping title: A Potential Target for Clinical Atherosclerosis: A Novel Insight Derived from TPM2 date: 2022-04-01 journal: Aging Dis DOI: 10.14336/ad.2021.0926 sha: 3bf7feee57fada9b8a6b2f952e3237e7d14bbbfe doc_id: 29266 cord_uid: wu4m8dvp Atherosclerosis (AS) is a potential inducer of numerous cardio-cerebrovascular diseases. However, little research has investigated the expression of TPM2 in human atherosclerosis samples. A total of 34 clinical samples were obtained, including 17 atherosclerosis and 17 normal artery samples, between January 2018 and April 2021. Bioinformatics analysis was applied to explore the potential role of TPM2 in atherosclerosis. Immunohistochemistry, immunofluorescence, and western blotting assays were used to detect the expression of TPM2 and α-SMA proteins. The mRNA expression levels of TPM2 and α-SMA were detected using RT-qPCR. A neural network and intima-media thickness model were constructed. A strong relationship existed between the intima-media thickness and relative protein expression of TPM2 (P<0.001, R=-0.579). The expression of TPM2 was lower in atherosclerosis than normal artery (P<0.05). Univariate logistic regression showed that TPM2 (OR=0.150, 95% CI: 0.026-0.868, P=0.034) had clear correlations with atherosclerosis. A neural network model was successfully constructed with a relativity of 0.94434. TPM2 might be an independent protective factor for arteries, and one novel biomarker of atherosclerosis. accumulate subcutaneously in the arterial wall and form lipid plaques [5, 6] . However, the molecular mechanisms underlying the formation and rupture of unstable plaques are not fully understood. TPM2 is a protein-coding gene, a subtype of the TPM family, which has the function of stabilizing and integrating actin filaments [7] . The associated pathways include cardiac conduction and dilated cardiomyopathy (DCM). In our previous research, tropomyosin 2 (TPM2) was reported as a potential predictive biomarker for atherosclerosis based on the screening of bioinformatics analysis and the verification of animal experiment. Compared with the non-atherosclerotic tissues, the expression of TPM2 was down-regulated in the atherosclerosis samples. Through the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, differently expressed genes (including TPM2) between non-atherosclerosis and atherosclerosis were primarily enriched in actin filament, actin binding, smooth muscle cells, and cytokine-cytokine receptor interactions. TPM2 might be a potential novel atherosclerosis suppressor gene in vascular tissues, and it might represent a promising therapeutic gene target for atherosclerotic patients [7] . However, no studies have yet confirmed whether the expression level of TPM2 in human AS tissues is lower than that of non-atherosclerosis tissues. Therefore, the aim of this study was to explore whether the expression of the TPM2 gene in human AS tissues is lower than that in non-atherosclerotic vessels. Lower expression of TPM2 in the clinical atherosclerosis samples, and strong correlation of the intima-media thickness, TPM2, and α-SMA AS is the primary basis for most cardiovascular diseases, including myocardial infarction and stroke [8] . The immunohistochemistry and immunofluorescence assays showed that the expression of TPM2 protein in the atherosclerosis group was lower than that in the normal group (P<0.05, Fig. 1A ). These results indicated that the relative expression level of TPM2 mRNA was significantly increased in artery tissue samples without atherosclerosis compared with artery tissue samples with atherosclerosis (P<0.05, Fig. 1B ). Pearson rho analysis showed that a strong relationship existed between the intima-media thickness and relative protein expression of TPM2 (P<0.001, R=-0.579). The intima-media thickness was also related to the relative protein expression of α-SMA (P<0.001, R=-0.688). In addition, a strong relationship existed between α-SMA and the relative protein expression of TPM2 (P<0.001, R=0.846, Fig. 1C) . A heatmap showed that there were strong correlations among the intima-media thickness, TPM2, and α-SMA (Fig. 1D ). ROC curves were constructed to determine the effect of TPM2 and α-SMA on the intima-media thickness, with the degree of confidence judged by the area under the curve (AUC)=0.855 (P<0.001, Fig. 1E ). Western blotting analysis showed that the expression of α-SMA and TPM2 proteins was lower in the atherosclerosis group than in the normal group (Fig. 1F) . Tropomyosins (TPMs) are a family of actin-binding proteins whose expression is highly tissue-specific. The role of TPMs is to stabilize and integrate actin filaments. In addition, TPMs are related to cell migration and morphological changes. TPMs are widely distributed in various eukaryotic cells in the form of a large number of isomers. Four TPM gene subtypes, TPM1, TPM2, TPM3, and TPM4, have been identified in mammals [9] . Lin et al. showed that Mir-183-5 p.1 inactivates the Bcl-2 /P53 signaling pathway and promotes cell proliferation, migration, and invasion by down-regulating TPM1 [10] . Cui et al. found that TPM2 is often silenced following abnormal DNA methylation, while the loss of TPM2 is associated with RhoA activation and cell proliferation [11] . Therefore, we hypothesized that TPM2 may be related to cell proliferation and migration during the development of atherosclerosis. Fig. 2A) , and the relativity was 0.94434 (Fig. 2B) . Then, the model was used to verify the results and showed there were no significant differences between the predicted and actual values (Fig. 2C, D) . Based on the above results, we speculate that the levels of TPM2 and α-SMA expression might be predictive indexes for intima-media thickness. Using the thin-plate spline interpolation, we found a high-risk warning indicator of the intima-media thickness: 0 < TPM2 < 80, and 0 < α-SMA < 40 (Fig. 2E) . The development of atherosclerosis is a complex process in which cellular components or cytokines in vascular smooth muscle cells (VSMCs), endothelial cells, and monocytes/macrophages play an important role [12] . In recent years, studies have shown that smooth muscle cells (SMCs) account for about 70% of the cells contained in AS plaques. Initially, SMC proliferation, migration, and synthesis of extracellular matrix leads to early damage in AS. Next, proinflammatory and pro-proliferative cytokines, secreted by SMCs, activate SMCs and recruit macrophages to the damaged sites. Finally, SMCs absorb lipids through lipoprotein receptors expressed on their cell membrane surfaces and form myogenic foam cells [13] [14] [15] . More importantly, SMCs cannot function without regulation by the TPM2 gene. Previous studies have shown that senescence in VSMCs can promote further development of atherosclerosis in atherosclerotic tissues, suggesting that the normal function of VSMCs is crucial for protecting vascular walls against atherosclerosis [16] . Traditionally, the SMCs of the endometrium are considered beneficial for the formation of fibrous caps that prevent plaques from rupturing. Bennet et al suggested that VSMC proliferation may be beneficial throughout atherosclerosis [14] . Thus, during the development of atherosclerosis, the down-regulated expression of TPM2 leads to formation and movement disorders of VSMCs. The low expression of TPM2 in the tissues of patients with AS may accelerate the apoptosis of VSMCs, which leads to the release of various inflammatory factors, such as IL-1 and IL-8, aggravating the inflammatory response in the plaque, increasing atheromatous substances in the lipid nucleus, and making the plaque more unstable. Meanwhile, the apoptosis of VSMCs reduces anticoagulant components and promotes the rapid exposure of the anticoagulant phosphatidylserine, thus promoting the formation of thrombus [17] . In addition, apoptotic VSMCs are not easily removed, and the remaining part becomes the main component of the calcification matrix, leading to vascular calcification [18] . This is followed by weakened vasoconstriction, which further accelerates the occurrence of cardiovascular and cerebrovascular diseases. Although this study has carried out a rigorous experimental design, there are still some deficiencies. There may be some selection bias in this paper. When conducting the research, the individuals in the study came from the one hospital, so selection bias will inevitably occur in the results. Due to the samples size is small, hypertension and smoking seemed not to be the risk factor for atherosclerosis when analyzing the relationship between characteristics of patients and atherosclerosis. However, sample collection was difficult because the number of surgeries for blood vessel has plummeted in this current pandemic of COVID-19. Furthermore, this research mainly focused on the significant role of TPM2 on the atherosclerosis. TPM2 might be a useful biomarker for the diagnosis and treatment of clinical atherosclerosis. Hypertension and smoking were only presented as traditionally basic characteristics of the patients, so that their value was not emphasized in this study. Therefore, in future studies, we will conduct a multi-center controlled clinical trial to collect more samples, and further research the relationships among TPM2, hypertension, smoking, and atherosclerosis. TPM2 was found to occur expressed at a low level in atherosclerotic plaques in patients. It was further found that TPM2 may be a useful biomarker for the diagnosis and treatment of atherosclerosis. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities Immunity, atherosclerosis and cardiovascular disease Inflammation in atherosclerosis KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis Immunity and Inflammation in Atherosclerosis Research Progress on the Relationship between Atherosclerosis and Inflammation TPM2 as a potential predictive biomarker for atherosclerosis Atherosclerosis: the interplay between lipids and immune cells Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines miRNA-183-5p.1 promotes the migration and invasion of gastric cancer AGS cells by targeting TPM1 Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation Vascular Smooth Muscle Cells Corrigendum: KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis Vascular Smooth Muscle Cells in Atherosclerosis Induction of MiR133a expression by IL-19 targets LDLRAP1 and reduces oxLDL uptake in VSMC Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies The present study was funded by the National Key The Supplemenantry data can be found online at: www.aginganddisease.org/EN/10.14336/AD.2021.0926. The data used to support the findings of this study are available from the corresponding author upon request.